Merz Pharma GmbH & Co. KGaA is an international healthcare company specializing in over-the-counter and prescription creams, ointments and injectables in the fields of dermatology, neurology and metabolic disorders.
Based in Frankfurt am Main, Germany, Merz is a leader in the field of Alzheimer's disease research and developed memantine as the first drug for the treatment of moderate to severe Alzheimer's disease.
Other franchises covered by Merz are hepatology / metabolic diseases and dermatology (including Mederma scar gel).
In Asia Pacific, the Merz franchise covers aesthetic dermatology (including Radiesse and Xeomin).
5 Rue de Castiglione, 75001 Paris ou
143 Avenue Maurice Racamond 84310 Morieres les Avignon
Tél. :+33 (0)952 005 843